Abstract:Crystalline materials are crucial to the function of living organisms, in the shells of molluscs, the matrix of bone, the teeth of sea urchins, and the exoskeletons of coccoliths. However, pathological biomineralization can be an undesirable crystallization process associated with human diseases. The crystal growth of biogenic, natural and synthetic materials may be regulated by the action of modifiers, most commonly inhibitors, which range from small ions and molecules to large macromolecules. Inhibitors adsorb on crystal surfaces and impede the addition of solute, thereby reducing the rate of growth. Complex inhibitor-crystal interactions in biomineralization are often not well elucidated. Here we show that two molecular inhibitors of calcium oxalate monohydrate crystallization--citrate and hydroxycitrate--exhibit a mechanism that differs from classical theory in that inhibitor adsorption on crystal surfaces induces dissolution of the crystal under specific conditions rather than a reduced rate of crystal growth. This phenomenon occurs even in supersaturated solutions where inhibitor concentration is three orders of magnitude less than that of the solute. The results of bulk crystallization, in situ atomic force microscopy, and density functional theory studies are qualitatively consistent with a hypothesis that inhibitor-crystal interactions impart localized strain to the crystal lattice and that oxalate and calcium ions are released into solution to alleviate this strain. Calcium oxalate monohydrate is the principal component of human kidney stones and citrate is an often-used therapy, but hydroxycitrate is not. For hydroxycitrate to function as a kidney stone treatment, it must be excreted in urine. We report that hydroxycitrate ingested by non-stone-forming humans at an often-recommended dose leads to substantial urinary excretion. In vitro assays using human urine reveal that the molecular modifier hydroxycitrate is as effective an inhibitor of nucleation of calcium oxalate monohydrate nucleation as is citrate. Our findings support exploration of the clinical potential of hydroxycitrate as an alternative treatment to citrate for kidney stones.

In Vitro Simulation on the Inhibition of Calcium Oxalate Calculus by Changing the Counterions of Citric Acid and EDTA

Modulation of Mixed Potassium Carboxylates on Crystallization of Calcium Oxalate Crystals in Gel System

Effect of Structurally-Specific Carboxylates on Biomineralization of Calcium Oxalate in Gel Systems

Role of E. Coli-Secretion and Melamine in Selective Formation of CaC2O4·H2O and CaC2O4·2H2O Crystals

Concave Urinary Crystallines: Direct Evidence of Calcium Oxalate Crystals Dissolution by CitrateIn Vivo

Inhibition of calcium oxalate monohydrate crystallization by the combination of citrate and osteopontin

Inhibition of Sodium Citrate on Aggregation and Sedimentation of Nanocalcium Oxalate Dihydrate Crystals

Simulation of Calcium Oxalate Stone in Vitro

Influences of Biomolecules and Complexing Agent on Crystallization of Calcium Oxalate in Agar Gel

Chemical Basis in Inhibition of Urinary Stones by Citric Acid and Its Salts

Inhibition Effect of Anti-stone Composition on Renal Calcium Oxalate Calculus Formation in Experimental Rats

Understanding the Role of Citric Acid on the Crystallization Pathways of Calcium Oxalate Hydrates

Simulation in Vitro on Inhibition of Calcium Oxalate Calculus in Lithogenic Urine by Sulfated Polysaccharide Isolated from Laminarin

Controlling influence of phosphocitrate in vitro and in vivo on calcium oxalate crystal formation and growth

Changes in urinary nanocrystallites in calcium oxalate stone formers before and after potassium citrate intake

Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps

Tartronic Acid As a Potential Inhibitor of Pathological Calcium Oxalate Crystallization

Dual Roles of Melamine in the Formation of Calcium Oxalate Stones

The kinetic study on restraining the growth of calcium oxalate crystal

Molecular modifiers reveal a mechanism of pathological crystal growth inhibition

The Effect of Extract of Lysimachia Christinae Hance on Calcium Oxalate Crystal Growth in Healthy Urine